最新消息
News

Bened Biomedical signs exclusive agreement with M8 Pharmaceuticals

Bened Biomedical has signed an exclusive licensing agreement with Mexico's leading pharmaceutical company M8 Pharmaceuticals (formerly moksha8).

精神益生菌PS128獲得美國GRAS安全性認證

全球十大精神益生菌關鍵企業之一的台灣益福生醫公司，日前宣布其旗下行銷全球40國的專利精神益生菌PS128，獲得美國GRAS（Generally Recognized as Safe一般公認安全）Self-affirmed安全性認證，為益福生醫精神益生菌的全球市場佈局再添重要利器。

全球十大精神益生菌關鍵企業名單出爐台灣益福生醫入列

全球權威市場調查機構Future Market Insights (FMI) 2020年6月份發布最新研究報告「精神益生菌營養補充品市場: 2015-2019全球產業分析及未來十年機會評估」，其中，在當前全球十大精神益生菌關鍵企業(Psychobiotic Supplements Market: Key Players) 名單中，更出現了亞洲唯一上榜、來自台灣的益福生醫，備受業界矚目。

At Bened Biomedical, our purpose is to help people with brain disorders to have happier lives.

Second day of April is World Autism Awareness Day. Autism or Autism Spectrum Disorder or ASD is a disorder characterized by deficits in social interaction and communication, and by the presence of restricted and repetitive behavior.

Bened Biomedical signed a deal with a major player in Australian and New Zealand markets

An exclusive deal on PS128™ has been signed between Bened and BioCeuticals, Australia’s leading provider of nutritional and therapeutic supplements, also a practitioner-only brand of the Blackmores Group.

<
1
2
3
4
5
6
7
8
>